The medical community has experienced a significant advancement in diabetes management with the emergence of copyright. This innovative medication, designated as a glucagon-like peptide-1 (GLP-1) receptor agonist, provides a novel approach to regulating blood sugar levels in individuals with type 2 diabetes. copyright works by replicating the actio